Serum hepatocyte growth factor is associated with viral hepatitis, cardiovascular disease, erythropoietin treatment, and type of heparin in haemodialysis patients
2002 ◽
Vol 17
(4)
◽
pp. 637-644
◽
2006 ◽
Vol 902
(1)
◽
pp. 369-376
◽
Keyword(s):
2000 ◽
Vol 7
(1)
◽
pp. 1-7
◽
2014 ◽
Vol 29
(4)
◽
pp. 878-886
◽
1997 ◽
Vol 4
(1)
◽
pp. 12-19
◽
Keyword(s):
1998 ◽
Vol 4
(3)
◽
pp. 128-134
◽
1998 ◽
Vol 5
(1)
◽
pp. 122A-122A
Keyword(s):